Massive Bio, a world-renowned provider of personalized oncology solutions, is set to showcase its groundbreaking GPT4 AI chatbots - AskFiona AI and …

Massive Bio, a leading artificial intelligence (AI) analytics company specializing in precision oncology, has been selected by the Precision Cancer…

Massive Bio, a leader in leveraging artificial intelligence and concierge services to empower cancer patients, is thrilled to announce a non-exclusive…

Nucleai, a leading provider of artificial intelligence (AI) solutions for pathology and spatial biology, and Mayo Clinic BioPharma Diagnostics are…

Massive Bio, a globally recognized leader in the oncology space, has proudly announced its appointment as a founding member of CancerX, a…

While there is no debate on the tremendous value that Generative AI can bring across the value chain, there are several potential risks for…

The creation of three new multidisciplinary research institutes in The Henry Samueli School of Engineering is being made possible by a $50 million…

New assets establish foundation for Eikon’s expanding pipeline of in-house and acquired drug candidates with applications in oncology and other…

The rapid development in the field of artificial intelligence continues to accelerate digital transformation in emerging economies in Southeast…

AI-enabled clinical assistant provides access to patient insights directly at your fingertips Tempus, a leader in artificial intelligence (AI) and…